Shopping Cart

No products in the cart.

AAMI 25539 2 2012

$162.84

ANSI/AAMI/ISO 25539-2:2012 – Cardiovascular implants-Endovascular devices-Part 2: Vascular stents

Published By Publication Date Number of Pages
AAMI 2012 116
Guaranteed Safe Checkout
Category:

If you have any questions, feel free to reach out to our online customer service team by clicking on the bottom right corner. We’re here to assist you 24/7.
Email:[email protected]

Specifies requirements for vascular stents, based upon current medical knowledge. Gives requirements for intended performance, design attributes, materials, design evaluation, manufacturing, sterilization packaging and information supplied by the manufacturer. Includes vascular stents used to treat vascular lesions or stenosis, or other vascular abnormalities. These devices may or may not incorporate surface modifications of the stent such as drug and/or other coatings.

PDF Catalog

PDF Pages PDF Title
1 ANSI/AAMI/ISO 25539-2:2012, Cardiovascular implants — Endovascular devices — Part 2: Vascular stents
2 Objectives and uses of AAMI standards and recommended practices
3 Title page
4 AAMI Standard
Copyright information
5 Contents
7 Glossary of equivalent standards
8 Committee representation
9 Background of ANSI/AAMI adoption of ISO 25539-2:2012
10 Foreword
11 Introduction
13 1 Scope
2 Normative references
14 3 Terms and definitions
17 4 General requirements
4.1 Classification
4.2 Size
4.3 Intended clinical use designation
18 5 Intended performance
6 Design attributes
6.1 General
19 6.2 Delivery system and stent system
6.3 Implant
6.3.1 Stent
6.3.2 Coating
20 6.3.3 Drug
7 Materials
8 Design evaluation
8.1 General
21 8.2 Sampling
8.3 Conditioning of test samples
22 8.4 Reporting
8.5 Delivery system and stent system
8.5.1 Ability to access
8.5.1.1 General
23 8.5.1.2 Bond strength
8.5.1.3 Component dimension compatibility
8.5.1.4 Dimensional verification
8.5.1.5 Dislodgement force (pre-mounted balloon expandable stents)
24 8.5.1.6 Flex/kink
8.5.1.7 Profile/diameter test
8.5.1.8 Pushability
8.5.1.9 Simulated use
8.5.1.10 Torquability
8.5.1.11 Torsional bond strength
8.5.1.12 Trackability
8.5.1.13 Visibility
8.5.2 Ability to deploy
8.5.2.1 General
25 8.5.2.2 Bond strength
8.5.2.3 Balloon inflation time (balloon expandable or balloon assisted stents)
8.5.2.4 Balloon deflation time (balloon expandable or balloon assisted stents)
8.5.2.5 Balloon rated burst pressure (RBP) (balloon expandable or balloon assisted stents)
26 8.5.2.6 Balloon rated fatigue (balloon expandable stents)
8.5.2.7 Component dimension compatibility
8.5.2.8 Dimensional verification
8.5.2.9 Dislodgement force (pre-mounted balloon expandable stents)
8.5.2.10 Dogboning (balloon expandable stents)
8.5.2.11 Force to deploy (self-expanding stents)
8.5.2.12 Simulated use
8.5.2.13 Visibility
8.5.3 Ability to withdraw
8.5.3.1 General
27 8.5.3.2 Bond strength
8.5.3.3 Component dimension compatibility
8.5.3.4 Dimensional verification
28 8.5.3.5 Flex/kink
8.5.3.6 Simulated use
8.5.3.7 Torsional bond strength
8.5.3.8 Tubing tensile strength
8.5.3.9 Visibility
8.5.4 Biocompatibility
8.5.5 Hemostasis
8.5.5.1 General
29 8.5.5.2 Component dimension compatibility
8.5.5.3 Dimensional verification
8.5.5.4 Assessment of hemostasis
8.6 Stent
8.6.1 Ability to accurately deploy
8.6.1.1 General
30 8.6.1.2 Stent length-to-diameter relationship
8.6.1.3 Profile effect/flaring (balloon expandable stents)
8.6.1.4 Simulated use
8.6.1.5 Visibility
8.6.2 Fixation effectiveness
8.6.2.1 General
31 8.6.2.2 Conformability to vessel wall
8.6.2.3 Crush resistance with a radially applied load (balloon expandable stents)
8.6.2.4 Crush resistance with parallel plates
8.6.2.5 Local compression
8.6.2.6 Radial force
8.6.2.7 Recoil (balloon expandable stents)
8.6.2.8 Simulated use
8.6.3 Stent integrity
8.6.3.1 General
32 8.6.3.2 Acute coating integrity
8.6.3.3 Coating dimensions and other coating parameters (e.g. porosity, density distribution, mass)
8.6.3.4 Corrosion
33 8.6.3.5 Durability
8.6.3.5.1 General
8.6.3.5.2 Stress/strain analyses
8.6.3.5.3 Fatigue safety factor determination
8.6.3.5.4 Fatigue durability testing
34 8.6.3.5.5 Coating durability
8.6.3.5.6 Coating particulate generation
8.6.3.6 Visual inspection
8.6.4 Sizing
8.6.4.1 General
35 8.6.4.2 Dimensional verification
8.6.4.3 Stent diameter to balloon inflation pressure (balloon expandable stents)
8.6.4.4 Recoil (balloon expandable stents)
8.6.4.5 Simulated use
8.6.4.6 Stent length to diameter relationship
36 8.6.5 Patency
8.6.5.1 General
37 8.6.5.2 Crush resistance test with a radially applied load (balloon expandable stents)
8.6.5.3 Crush resistance with parallel plates
8.6.5.4 Flex/kink
8.6.5.5 Local compression
8.6.5.6 Radial force
8.6.5.7 Simulated use
8.6.5.8 Stent-free surface area and stent outer surface area
8.6.6 Magnetic resonance imaging (MRI) safety and compatibility
38 8.6.7 Biocompatibility
8.6.8 Drug elution
8.6.8.1 General
39 8.6.8.2 Drug content/amount
8.6.8.3 Elution profile
8.6.8.4 Drug identity
8.7 Preclinical in vivo evaluation
8.7.1 Purpose
8.7.2 Specific aims
40 8.7.3 Protocol
8.7.4 Data acquisition
42 8.7.5 Test report and additional information
43 8.8 Clinical evaluation
8.8.1 Purpose
8.8.2 Specific aims
44 8.8.3 Clinical investigation plan
8.8.4 Data acquisition during clinical investigations
46 8.8.5 Final report
48 9 Post-market surveillance
10 Manufacturing
11 Sterilization
11.1 Products supplied sterile
11.2 Products supplied non-sterile
11.3 Sterilization residuals
49 12 Packaging
12.1 Protection from damage in storage and transport
12.1.1 General
12.1.2 Unit container
12.1.3 Outer container
12.1.4 Shipping container
12.1.5 Maintenance of sterility in transit
12.2 Marking
12.2.1 Container label
12.2.2 Stents without delivery systems
50 12.2.3 Stent systems (stents with delivery system)
12.2.4 Record label
12.3 Information supplied by the manufacturer
12.3.1 General
51 12.3.2 Information and instructions for use (IFU)
52 Annex A (informative) Attributes of endovascular devices — Vascular stents — Technical and clinical consideration
59 Annex B (informative) Bench and analytical tests
63 Annex C (informative) Definitions of reportable clinical events
66 Annex D (informative) Test methods
D.1 General
D.2 Sampling
67 D.3 Conditioning of test samples
D.4 Reporting
68 D.5 Test methods
D.5.1 Stent system
D.5.1.1 Dimensional verification and component dimension compatibility
D.5.1.1.1 Purpose
D.5.1.1.2 Materials
D.5.1.1.3 Sampling
D.5.1.1.4 Conditioning
D.5.1.1.5 Test method
69 D.5.1.1.6 Expression of results
D.5.1.1.7 Test report
D.5.1.2 Profile/diameter test
D.5.1.2.1 Purpose
D.5.1.2.2 Materials
D.5.1.2.3 Sampling
70 D.5.1.2.4 Conditioning
D.5.1.2.5 Test method
D.5.1.2.6 Expression of results
D.5.1.2.7 Test report
D.5.1.3 Simulated use
D.5.1.3.1 Purpose
D.5.1.3.2 Materials
71 D.5.1.3.3 Sampling
D.5.1.3.4 Conditioning
D.5.1.3.5 Test method
D.5.1.3.6 Expression of results
D.5.1.3.7 Test report
72 D.5.1.4 Visibility
D.5.1.4.1 Purpose
D.5.1.4.2 Materials
D.5.1.4.3 Sampling
D.5.1.4.4 Conditioning
D.5.1.4.5 Test method
D.5.1.4.6 Expression of results
73 D.5.1.4.7 Test report
D.5.1.5 Force to deploy
D.5.1.5.1 Purpose
D.5.1.5.2 Materials
D.5.1.5.3 Sampling
D.5.1.5.4 Conditioning
D.5.1.5.5 Test method
74 D.5.1.5.6 Expression of results
D.5.1.5.7 Test report
D.5.1.6 Balloon inflation and deflation time (balloon expandable or balloon assisted stents)
D.5.1.6.1 Purpose
D.5.1.6.2 Materials
D.5.1.6.3 Sampling
75 D.5.1.6.4 Conditioning
D.5.1.6.5 Test method
D.5.1.6.6 Expression of results
D.5.1.6.7 Test report
D.5.1.7 Balloon rated burst pressure (RBP) (balloon expandable or balloon assisted stents)
D.5.1.7.1 Purpose
D.5.1.7.2 Materials
76 D.5.1.7.3 Sampling
D.5.1.7.4 Conditioning
D.5.1.7.5 Test method
77 D.5.1.7.6 Expression of results
D.5.1.7.7 Test report
D.5.1.8 Balloon rated fatigue (balloon expandable or balloon-assisted stents)
D.5.1.8.1 Purpose
D.5.1.8.2 Materials
78 D.5.1.8.3 Sampling
D.5.1.8.4 Conditioning
D.5.1.8.5 Test method
D.5.1.8.6 Expression of results
D.5.1.8.7 Test report
79 D.5.2 Delivery system
D.5.2.1 Bond strength
D.5.2.1.1 Purpose
D.5.2.1.2 Materials
D.5.2.1.3 Sampling
D.5.2.1.4 Conditioning
D.5.2.1.5 Test method
D.5.2.1.6 Expression of results
D.5.2.1.7 Test report
80 D.5.2.2 Torsional bond strength
D.5.2.2.1 Purpose
D.5.2.2.2 Materials
D.5.2.2.3 Sampling
D.5.2.2.4 Conditioning
D.5.2.2.5 Test method
D.5.2.2.6 Expression of results
D.5.2.2.7 Test report
81 D.5.3 Stent
D.5.3.1 Stent diameter to balloon inflation pressure
D.5.3.1.1 Purpose
D.5.3.1.2 Materials
D.5.3.1.3 Sampling
D.5.3.1.4 Conditioning
D.5.3.1.5 Test method
82 D.5.3.1.6 Expression of results
D.5.3.1.7 Test report
D.5.3.2 Dimensional verification and stent length to diameter relationship
D.5.3.2.1 Purpose
D.5.3.2.2 Materials
D.5.3.2.3 Sampling
83 D.5.3.2.4 Conditioning
D.5.3.2.5 Test method
D.5.3.2.6 Expression of results
D.5.3.2.7 Test report
84 D.5.3.3 Recoil
D.5.3.3.1 Purpose
D.5.3.3.2 Materials
D.5.3.3.3 Sampling
D.5.3.3.4 Conditioning
D.5.3.3.5 Test method
85 D.5.3.3.6 Expression of results
D.5.3.3.7 Test report
D.5.3.4 Crush resistance with radially applied load
D.5.3.4.1 Purpose
D.5.3.4.2 Materials
86 D.5.3.4.3 Sampling
D.5.3.4.4 Conditioning
D.5.3.4.5 Test method
D.5.3.4.6 Expression of results
D.5.3.4.7 Test report
D.5.3.5 Crush resistance with parallel plates
D.5.3.5.1 Purpose
87 D.5.3.5.2 Materials
D.5.3.5.3 Sampling
D.5.3.5.4 Conditioning
D.5.3.5.5 Test method
88 D.5.3.5.6 Expression of results
D.5.3.5.7 Test report
D.5.3.6 Flex/kink
D.5.3.6.1 Purpose
D.5.3.6.2 Materials
89 D.5.3.6.3 Sampling
D.5.3.6.4 Conditioning
D.5.3.6.5 Test method A
D.5.3.6.6 Test method B
90 D.5.3.6.7 Expression of results
D.5.3.6.8 Test report
D.5.3.7 Local compression
D.5.3.7.1 Purpose
91 D.5.3.7.2 Materials
D.5.3.7.3 Sampling
D.5.3.7.4 Conditioning
D.5.3.7.5 Test method
D.5.3.7.6 Expression of results
92 D.5.3.7.7 Test report
D.5.3.8 Radial force
D.5.3.8.1 Purpose
D.5.3.8.2 Materials
D.5.3.8.3 Sampling
93 D.5.3.8.4 Conditioning
D.5.3.8.5 Test method
D.5.3.8.6 Expression of results
D.5.3.8.7 Test report
D.5.3.9 Corrosion assessment
D.5.3.9.1 Purpose
D.5.3.9.2 Materials
94 D.5.3.9.3 Sampling
D.5.3.9.4 Conditioning
D.5.3.9.5 Test method
D.5.3.9.6 Expression of results
D.5.3.9.7 Test report
D.5.3.10 Fatigue durability test
D.5.3.10.1 Purpose
95 D.5.3.10.2 Materials
D.5.3.10.3 Sampling
96 D.5.3.10.4 Conditioning
D.5.3.10.5 Test method
99 D.5.3.10.6 Expression of results
100 D.5.3.10.7 Test report
D.5.3.11 Stress/strain analyses (e.g. finite element analysis)
D.5.3.11.1 Purpose
D.5.3.11.2 Materials
D.5.3.11.3 Sampling
D.5.3.11.4 Methodology of analysis
101 D.5.3.11.5 Expression of results
D.5.3.11.6 Test report
102 D.5.3.12 Dislodgment force (premounted balloon-expandable stents)
D.5.3.12.1 Purpose
D.5.3.12.2 Materials
D.5.3.12.3 Sampling
D.5.3.12.4 Conditioning
103 D.5.3.12.5 Test method
D.5.3.12.6 Expression of results
D.5.3.12.7 Test report
D.5.3.13 Dogboning (balloon expandable stents)
D.5.3.13.1 Purpose
D.5.3.13.2 Materials
104 D.5.3.13.3 Sampling
D.5.3.13.4 Conditioning
D.5.3.13.5 Test method
D.5.3.13.6 Expression of results
D.5.3.13.7 Test report
105 D.5.3.14 Profile effect/flaring
D.5.3.14.1 Purpose
D.5.3.14.2 Materials
D.5.3.14.3 Sampling
D.5.3.14.4 Conditioning
D.5.3.14.5 Test method
106 D.5.3.14.6 Expression of results
D.5.3.14.7 Test report
D.5.3.15 Stent-free surface area and stent outer surface area
D.5.3.15.1 Purpose
D.5.3.15.2 Materials
D.5.3.15.3 Sampling
D.5.3.15.4 Methodology of analysis
107 D.5.3.15.5 Expression of results
D.5.3.15.6 Test report
D.5.3.16 Acute coating integrity
D.5.3.16.1 Purpose
D.5.3.16.2 Materials
D.5.3.16.3 Sampling
D.5.3.16.4 Conditioning
108 D.5.3.16.5 Test method
D.5.3.16.6 Expression of results
D.5.3.16.7 Test report
109 Annex E (informative) Supplement to fatigue durability test analytical approach
E.1 Zero longitudinal strain (constant length) condition — Sample equations for calculation of the inner diameter (or radius) from the outer diameter (or radius) for the zero longitudinal strain (constant length) condition
110 E.2 Zero longitudinal stress (unconstrained length) condition — Sample equations for calculation of the inner diameter (or radius) from the outer diameter (or radius) for the zero longitudinal stress (unconstrained length) condition
112 Bibliography
AAMI 25539 2 2012
$162.84